Hemoglobin enhances miRNA-144 expression and autophagic activation mediated inflammation of microglia via mTOR

Zhenyu Wang1, Bangqing Yuan2, Fenlan Fu2

  • 1Department of rehabilitation medicine, Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160, China.

Scientific Reports
|September 21, 2017
PubMed

Insights

Intracerebral hemorrhage activates microglia via miRNA-144, promoting inflammation. This microRNA targets mTOR, suggesting a new therapeutic approach for brain hemorrhage by modulating this pathway.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Intracerebral hemorrhage (ICH) triggers microglial autophagy and neuroinflammation.
  • MicroRNAs (miRNAs) regulate autophagy posttranscriptionally, but specific miRNAs in ICH-induced microglial autophagy are unknown.

Purpose of the Study:

  • To identify specific miRNAs involved in ICH-mediated microglial autophagic activation.
  • To elucidate the regulatory pathway of identified miRNAs in microglia.

Main Methods:

  • Microglia were treated with hemoglobin (Hb).
  • miRNA-144 expression, autophagic activation, and inflammation were measured.
  • The mechanistic target of rapamycin (mTOR) was identified as a target of miRNA-144.

Main Results:

  • Hemoglobin exposure increased miRNA-144 expression and induced autophagic activation and inflammation in microglia.
  • miRNA-144 directly targets the 3' UTR of mTOR, regulating its function.
  • Overexpression of mTOR attenuated the autophagic activation and inflammation.

Conclusions:

  • miRNA-144 mediates hemoglobin-induced microglial autophagic activation and inflammation through the mTOR pathway.
  • miRNA-based therapies offer a potential strategy for treating intracerebral hemorrhage.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K